To investigate the presence of recombination, we used the homoplasy test [34], which is a sensitive analysis of polymorphisms designed to detect rare recombination events. illness [1,2]. AlthoughPneumocystiscan infect a wide range of mammals, there is a strong sponsor restriction, such that each Fenretinide sponsor varieties is definitely infected by genetically unique strains that appear to representPneumocystisspecies, with, for example,Pneumocystisjirovecii infecting humans,Pneumocystiscarinii infecting rats, andPneumocystismurina infecting mice [37]. The life cycle ofPneumocystisremains uncertain, in large part because the organism cannot be reliably cultured. To date, there has been limited indirect evidence of a sexual phase with this organism, based on visualization of synaptonemal complexes by electron microscopy or recognition of genes inPneumocystisthat are associated with a sexual phase in additional organisms [814]. We have used 2 approaches to provide further support for any sexual phase in thePneumocystislife cycle. First, we undertook to identify and characterizePneumocystisgenes that are associated with meiosis in additional organisms. In eukaryotes, 2 recombinases, Rad51 and Dmc1, are involved in meiotic recombination [15,16]. We have previously characterized Rad51 ofPneumocystis, which is definitely indicated during both mitosis and meiosis [17]. In the present study, we have cloned and characterized manifestation ofPneumocystisDmc1 (disrupted meiotic complementary DNA [cDNA]), which in candida is definitely indicated specifically during meiosis [15,16,18]. As a second approach, we undertook to identify recombination in regions of thePneumocystisgenome that are present as solitary copies. BecausePneumocystisorganisms, regardless of the stage in the life cycle (trophic form, sporocytes, or individual spores), contain primarily haploid MYCNOT DNA [1921], such recombination would provide supportive evidence for any sexual phase. We examined 2 single-copy areas: the unique subtelomeric manifestation site of themsggene family, which is a multicopy gene family that encodes related but unique variants of the major surface glycoprotein (Msg). This manifestation site includes a putative promoter, a 5 untranslated region (UTR), and an N-terminal innovator peptide [2227] required for msg manifestation. We also examined the upstream and coding region of the dihydrofolate reductase gene ofPneumocystis. == Methods == Pneumocystis DNA and RNA preparation.P. cariniiorganisms were isolated from your lungs of immunosuppressed rats by Ficoll-Hypaque denseness gradient centrifugation [28].P. murina-infected lungs were from scid mice.P. jirovecii- infected autopsy lung, bronchoalveolar lavage, or induced sputum samples were from individuals withPneumocystispneumonia. Genomic DNA was isolated using the QIAamp DNA Mini kit (Qiagen), and total RNA was extracted using RNAzol B (Tel-Test). Human being- and animal-experimentation recommendations of the National Institutes of Health were adopted in the conduct of these studies. Polymerase chain reaction amplification of dmc1.Polymerase chain reaction (PCR) was performed using Large Fidelity PCR expert blend (Roche Diagnostics) or HotStarTaq(Qiagen). General PCR conditions used were as follows: initial denaturation cycle of 2 min at 94C; followed by 35 cycles of 30 s at 94C, 30 s at 50C, and 2 min at 72C; and a final extension of 10 min at 72C. The annealing temp was optimized for each set of primers. For HotStarTaq, an initial denaturation cycle of 15 min at 95C was used. Sequences of the primers utilized for amplification are outlined inTable 1. Amplification products were electrophoretically separated on E-Gels (Invitrogen) comprising ethidium bromide and visualized under UV light. == Table 1. == Sequences of Oligonucleotides Used in the Study Reverse-transcriptase (RT) PCR was performed with firststrand cDNA synthesized from total RNA acquired fromP. cariniiorP. murina, using AP primer and Superscript II reverse transcriptase (Invitrogen).dmc1fromP. murinacDNA was amplified by nested PCR, using primers GK609 and GK613 for the 1st round and GK617 and GK619 for the second round. For the amplification ofP. carinii dmc1, a seminested PCR was Fenretinide performed with primers GK609 and GK613 for the 1st round and GK615 and GK613 for the second round. For 3 quick amplification of cDNA ends (RACE), cDNA was synthesized from RNA preparations with primer Fenretinide AP and superscript II (3-RACE kit; Invitrogen), followed by PCR amplification with primer UAP and dmc1 gene-specific primers GK620 and GK617 forP. murinaandP. carinii, respectively. RNA fromP. cariniiorP. murinawas subjected to RNA ligase-mediated RACE, using the First Fenretinide Choice RLM-RACE kit (Ambion) in accordance with the manufacturer’s protocol. A seminested PCR was performed with gene-specific primers GK5dmc1 forP. cariniiand GK3dmc1 forP. murina, along with outer and inner adapter primers. Partial genomic sequence.